Neurogene (NGNE) Price to Sales (2019 - 2025)
Neurogene's (NGNE) Price to Sales was 340.30 for Q2 2025, down 48.9% from 666.49 a year earlier.
Powered by 
Analysis
Neurogene (NGNE) Price to Sales (2019 - 2025) Analysis & Trends
For FY2024, Price to Sales at Neurogene was 367.11.
- The Q2 2025 figure ranks as the lowest quarterly Price to Sales since Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Neurogene | 578.46 Mn | 578.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 340.30 |
| Dec 31, 2024 | 367.11 |
| Sep 30, 2024 | 769.04 |
| Jun 30, 2024 | 666.49 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.05 |
| Sep 30, 2019 | 0.08 |
API Access
Neurogene Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();